- New alliance will crack down on adulterated products touting dietary supplement claims
- Pharmacists engage with patients in campaign for improved nutrition
- UnitedHealth: Cost of diabetes could be $3.35 trillion by 2020
- Report: More than a quarter of U.S. kids take at least one chronic med
- FDA issues warning about fraudulent Tamiflu
EXTON, Pa. — ViroPharma has received approval for updated labeling to its antibiotic drug.
The drug maker announced that the Food and Drug Administration approved the "modernization" of labeling for Vancocin (vancomycin hydrochloride) capsules. The new label includes clinical safety and efficacy data for the drug in treatment strains of Clostridium difficile bacteria currency circulating.
"This new label provides physicians a better understanding about how to treat and monitor patients suffering from the serious and often life-threatening infections that require oral Vancocin therapy," ViroPharma president and CEO Vincent Milano said.